COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma

• Hoofdauteurs: Zongheng Liu (Auteur), Long Peng (Auteur), Yidan Sun (Auteur), Zhichao Lu (Auteur), Bing Wu (Auteur), Weichen Wang (Auteur), Xiaomei Zhang (Auteur), Haiyan Hao (Auteur), Peipei Gong (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Glioma as the most frequently discovered tumor affecting the brain shows significant morbidity and fatality rates with unfavorable prognosis. There is an urgent need to find novel therapeutic targets to overcome the low chemotherapeutic efficacy of glioma. This research examined whether...